First Community Trust NA Purchases Shares of 8,590 DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

First Community Trust NA purchased a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the 4th quarter, Holdings Channel.com reports. The fund purchased 8,590 shares of the medical instruments supplier’s stock, valued at approximately $163,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. UMB Bank n.a. grew its stake in shares of DENTSPLY SIRONA by 430.3% in the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock valued at $25,000 after buying an additional 753 shares in the last quarter. Capital Performance Advisors LLP acquired a new stake in DENTSPLY SIRONA in the third quarter valued at $27,000. Kennebec Savings Bank bought a new position in shares of DENTSPLY SIRONA in the 3rd quarter valued at about $35,000. Van ECK Associates Corp acquired a new position in shares of DENTSPLY SIRONA during the 3rd quarter worth about $42,000. Finally, Allworth Financial LP raised its holdings in shares of DENTSPLY SIRONA by 40.2% in the 3rd quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier’s stock valued at $59,000 after purchasing an additional 625 shares during the period. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Price Performance

Shares of XRAY stock opened at $18.06 on Wednesday. The business has a fifty day simple moving average of $18.96 and a 200 day simple moving average of $22.98. The company has a market cap of $3.59 billion, a P/E ratio of -8.72, a P/E/G ratio of 1.93 and a beta of 0.96. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a twelve month low of $17.21 and a twelve month high of $36.63.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. The firm had revenue of $951.00 million during the quarter, compared to analysts’ expectations of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business’s revenue for the quarter was up .4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.49 earnings per share. On average, sell-side analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, January 10th. Shareholders of record on Friday, December 27th were paid a dividend of $0.16 per share. The ex-dividend date was Friday, December 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.54%. DENTSPLY SIRONA’s payout ratio is presently -30.92%.

Analysts Set New Price Targets

A number of research analysts recently weighed in on XRAY shares. Mizuho began coverage on DENTSPLY SIRONA in a report on Wednesday, December 4th. They set a “neutral” rating and a $21.00 target price on the stock. UBS Group decreased their price objective on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating on the stock in a report on Tuesday, December 3rd. Needham & Company LLC cut their target price on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a research note on Friday, October 25th. Evercore ISI reaffirmed an “in-line” rating and set a $20.00 target price on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. Finally, Barrington Research lowered their price target on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a report on Friday, November 8th. Nine research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, DENTSPLY SIRONA presently has an average rating of “Hold” and a consensus price target of $27.27.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.